about
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboratio...
Read More
4.66
-0.01
(-0.21%)
1.1M
XNAS Volume
XNAS 05 Jan, 2026 4:30 PM (EST)
Medium Financial Strength
Affordable Valuation
Technically Neutral
Mid-range Performer
These stocks have affordable valuations, but mid range financials and momentum
View Similar
Embed DVM
CureVac N.V. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..